Inquire About a Product| Product: | Batimastat | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | 17367 | ||||||||
| CAS Number: | 130370-60-4 | ||||||||
| Pricing: |
|
||||||||
| Formula: | C23H31N3O4S2 | ||||||||
| Chemical Purity: | >98% | ||||||||
| Molecular Weight: | 477.64 | ||||||||
| Structure: |
|
||||||||
| Appearance: | Solid | ||||||||
| Category: | Anti-cancer compounds | ||||||||
| Stability: | Stable under recommended storage conditions. | ||||||||
| Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C. |
||||||||
| Transportation: |
Non-hazardous for transport |
||||||||
| Literature References: |
Walker EJ, Rosenberg GA, Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J. Neurosci. Res. 4, 764-73, (2010); Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E.,, Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J. Pathol. 4, 538-45, (2001); Krüger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, Harbeck N, Gänsbacher B, Schmitt M.,, Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res. 4, 1272-5, (2001) |
||||||||
| MSDS: | |||||||||
| Description: |
Batimastat is a potent, broad spectrum matrix metalloprotease (MMP) inhibitor |